Structure of the dopamine D2 receptor in complex with the antipsychotic drug spiperone
In addition to the serotonin 5-HT 2A receptor (5-HT 2A R), the dopamine D 2 receptor (D 2 R) is a key therapeutic target of antipsychotics for the treatment of schizophrenia. The inactive state structures of D 2 R have been described in complex with the inverse agonists risperidone (D 2 R ris ) and...
Uloženo v:
| Vydáno v: | Nature communications Ročník 11; číslo 1; s. 6442 - 11 |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , , , , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
London
Nature Publishing Group UK
22.12.2020
Nature Publishing Group Nature Portfolio |
| Témata: | |
| ISSN: | 2041-1723, 2041-1723 |
| On-line přístup: | Získat plný text |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Shrnutí: | In addition to the serotonin 5-HT
2A
receptor (5-HT
2A
R), the dopamine D
2
receptor (D
2
R) is a key therapeutic target of antipsychotics for the treatment of schizophrenia. The inactive state structures of D
2
R have been described in complex with the inverse agonists risperidone (D
2
R
ris
) and haloperidol (D
2
R
hal
). Here we describe the structure of human D
2
R in complex with spiperone (D
2
R
spi
). In D
2
R
spi
, the conformation of the extracellular loop (ECL) 2, which composes the ligand-binding pocket, was substantially different from those in D
2
R
ris
and D
2
R
hal
, demonstrating that ECL2 in D
2
R is highly dynamic. Moreover, D
2
R
spi
exhibited an extended binding pocket to accommodate spiperone’s phenyl ring, which probably contributes to the selectivity of spiperone to D
2
R and 5-HT
2A
R. Together with D
2
R
ris
and D
2
R
hal
, the structural information of D
2
R
spi
should be of value for designing novel antipsychotics with improved safety and efficacy.
The dopamine D
2
receptor (D
2
R) is a GPCR and an important drug target for schizophrenia treatment. Here, the authors present the crystal structure of human D
2
R in complex with the antipsychotic drug spiperone, which is of interest for designing antipsychotics with improved receptor selectivity. |
|---|---|
| Bibliografie: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| ISSN: | 2041-1723 2041-1723 |
| DOI: | 10.1038/s41467-020-20221-0 |